Art Therapy in Acute Schizophrenia (KUSS)

Charité University Medicine Berlin

Status: Completed

Conditions: Schizophrenia

Treatments: Behavioral: psychodynamic art therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01622166

EA1/104/11

Details and patient eligibility

About

Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.

*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.

*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of schizophrenia according to DSM-IV-TR
• age 18-64 yrs
• sufficient German language competency
• written informed consent

Exclusion criteria

• axis-I mental disorders other than schizophrenia
• comorbid antisocial personality disorder, relevant substance abuse,
• relevant severe somatic disease
• acute suicidal tendencies or aggression
• incapability to tolerate group settings

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

art therapy

Experimental group

Description:

12 sessions of art therapy / 6 weeks

Treatment:

Behavioral: psychodynamic art therapy

TAU

No Intervention group

Description:

treatment as usual / 6 weeks